logo

For the Inventor, By the Inventor

Basel, Switzerland

Knut A Jaeggi

This inventor holds 32 USPTO granted patents, primarily in Pharmaceutical Compositions. Top assignees: Ciba-Geigy Corporation, C-G Corp.. Active years: 1976-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Knut A Jaeggi. Retrieved from https://idiyas.com/inventor/knut-a-jaeggi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32

% Patents Active = 100.0

Average Co-Inventor Count = 1.9

ph-index = 7

Forward Citations = 324(Granted Patents)


Company Filing History:

goldMedal31 out of 6,858 
 
Ciba-Geigy Corporation
 patents
silverMedal1 out of 1 
 
C-G Corp.
 patent

Years Active: 1976-1995

Loading Chart...
Areas of Expertise:
Aminomethanediphosphonic Acids
Pharmaceutical Compositions
Azacycloalkyl Derivatives
Benzopyrane Derivatives
Cyclic-Substituted Derivatives
Heart Treatments
Etherified Hydroxy Compounds
Pyridine Derivatives
Heterocyclic Amidines
Alkanediphosphonic Acids
Phenoxy Substituted Glycosides
Pyrrolyl Compounds
32 patents (USPTO):Explore Patents
1. 5457094 - Heterocyclic amidines useful for treating diseases associated with (1995-10-10),
2. 5413994 - Pharmaceutical compositions containing di-phosphonic acid amidines (1995-05-09),
3. 5281748 - N-substituted aminomethanediphosphonic acids (1994-01-25),
4. 5204334 - Benzoheterocyclylalkylaminoalkanediphosphonic acids, compositions (1993-04-20),
5. 5190930 - Araliphatylaminoalkanediphosphonic acids (1993-03-02),
6. 5162310 - Phenylaliphatylaminoalkanediphosphonic acids (1992-11-10),
7. 5110807 - Araliphatylaminoalkanediphosphonic acids (1992-05-05),
8. 5057505 - Substituted aminomethanediphosphonic acids and use in medicaments (1991-10-15),
9. 5036058 - N-substituted aminoalkanediphosphonic acids (1991-07-30),
10. 4939130 - Substituted alkanediphosphonic acids and pharmaceutical use (1990-07-03),
11. 4929606 - Azacycloalkylalkanediphosphonic acids useful for treating diseases (1990-05-29),
12. 4871720 - Aromatically substituted azacycloalkyl-alkanediphosphonic acids useful (1989-10-03),
13. 4444768 - Pyrimido[1,6-a]indoles, pharmaceutical preparations containing them, and (1984-04-24),
14. 4410530 - 2-(3-Amino-2-hydroxy-propoxy)-mono-and diazines (1983-10-18),
15. 4327091 - N,N-Di and N,N,N-tri(hydroxy-lower alkyl) ammonium salts of substituted (1982-04-27),

Title: Knut A Jaeggi: Innovator in Pharmacological Properties

Introduction:

In the realm of pharmacological innovation, Knut A Jaeggi has emerged as a prominent figure with his groundbreaking patents and valuable contributions to the field. With a location in Basel, Switzerland, Jaeggi has amassed an impressive portfolio of 32 patents, showcasing his expertise and dedication to advancing the realms of disease treatment and calcium metabolism regulation. Let us delve into his latest patents, highlights from his career, noteworthy collaborations, and appreciate his remarkable contributions to the field.

Latest Patents:

Among Jaeggi's notable patents are his advancements in heterocyclic amidines used in treating diseases associated with compounds of formula I. These compounds, with defined characteristics of R, R.sub.1, R.sub.2, and q, exhibit significant pharmacological properties and prove to be effective calcium metabolism regulators. These valuable innovations are prepared using known methods and have the potential to revolutionize disease treatment.

Career Highlights:

Throughout his career, Jaeggi has worked with renowned companies, including Ciba-Geigy Corporation and C-G Corporation. These collaborations have allowed him to expand his knowledge, expertise, and research capabilities. His contributions to the field have garnered recognition, cementing his position as an esteemed innovator in pharmacology.

Collaborations:

Jaeggi's partnerships with fellow inventors have significantly contributed to his success. Notably, he has collaborated with Herbert Schroter and Franz Ostermayer, both esteemed professionals in their own right. Their joint efforts have led to the development of revolutionary pharmaceutical compositions and advancements in calcium metabolism regulation.

Conclusion:

In the world of pharmaceutical innovation, Knut A Jaeggi's patents and inventions stand as a testament to his unwavering dedication to advancing disease treatment and calcium metabolism regulation. With 32 patents to his name, Jaeggi has proven himself as a remarkable innovator, leaving an indelible mark on the field of pharmacology. We eagerly anticipate his future endeavors and the positive impact they will undoubtedly bring to the healthcare industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…